Inovio to report second quarter 2024 financial results on august 8, 2024

Plymouth meeting, pa. , july 25, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer, and infectious diseases, today announced that second quarter 2024 financial results will be released after the market close on august 8, 2024.
INO Ratings Summary
INO Quant Ranking